InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-18.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Madan Ajay, Directeur du Développement. Insider active across 1 company, notably Crinetics Pharmaceuticals, Inc.. In total, 3 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €209k. Activity tracked since 28 October 2021. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations3 total
13,950 shares0Common StockSEC:0001209191-22-015131:0
13,411 shares@ US$17.82750.0047% mcap37.9% of flowCommon StockSEC:0001209191-22-008061:0
106,383 shares@ US$0.730.0015% mcap12.1% of flowCommon StockSEC:0001209191-21-062263:0
3 of 3 declarations
About Madan Ajay
Ajay Madan is the Chief Development Officer at Crinetics Pharmaceuticals, Inc. He is responsible for product development strategy and innovation within the company.
